Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis.
Recommendations for the management of multiple sclerosis relapses.
Catheter venography and endovascular treatment of chronic cerebrospinal venous insufficiency.
Correction: Adherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain.
Abstracts of ECTRIMS (Congress of the European Committee for Treatment and Research in Multiple Sclerosis) 2013. October 2-5, 2013. Copenhagen, Denmark.
Different mechanisms underlying changes in excitability of peripheral nerve sensory and motor axons in multiple sclerosis.
Interferon-β Suppresses Murine Th1 Cell Function in the Absence of Antigen-Presenting Cells.
Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients.
Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).
Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice.
Including known covariates can reduce power to detect genetic effects in case-control studies.
Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis.
Premorbid physical activity predicts disability progression in relapsing-remitting multiple sclerosis.
Hormone and immune system interactions in demyelinating disease.
Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US.
Psychiatric disorders in neurology.
Pharmacokinetic evaluation of teriflunomide for the treatment of multiple sclerosis.
Disease Suppression Persists With Ozanimod at 72 Weeks in MS
Relationship between Sustained Disability Progression and Functional System Scores in Relapsing-Remitting Multiple Sclerosis: Analysis of Placebo Data from Four Randomized Clinical Trials.
Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers.
Stelara (Ustekinumab) receives FDA Approval for Treatment of Moderate to Severe Plaque Psoriasis with Four-Times-A-Year Maintenance Dosing
Effect of Glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab.
Remyelination induced by a DNA aptamer in a mouse model of multiple sclerosis.
HLA-A(∗)02, gender and tobacco smoking, but not multiple sclerosis, affects the IgG antibody response against human herpesvirus 6.
2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--I. Anticonvulsant properties.

Pages